KATHLEEN WATERS: Open Payments
NPI 1295028959 · SUMMERVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,859 in 59 payments from 16 companies in 2025. Trend: 2023 $928 · 2024 $1,492 · 2025 $1,859
Food & beverage: $1,859
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 6 | $445 |
| Vanda Pharmaceuticals Inc. | 6 | $265 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $223 |
| Supernus Pharmaceuticals, Inc. | 5 | $139 |
| Alkermes, Inc. | 6 | $119 |
| Axsome Therapeutics, Inc. | 4 | $103 |
| ABBVIE INC. | 5 | $100 |
| Lundbeck LLC | 4 | $94 |
| Teva Pharmaceuticals USA, Inc. | 3 | $93 |
| Neurocrine BioSciences, Inc. | 2 | $59 |
Products named: COBENFY, CAPLYTA, HETLIOZ, Qelbree, FANAPT, REXULTI, Auvelity, VRAYLAR.
Industry payments across SC — which companies pay providers there.
